Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2025		Mar. 31, 2024
Revenues [Abstract]
Revenue	$ 121,463,000		$ 74,999,000
Operating expenses:
Cost of revenue (excluding amortization and depreciation)	9,789,000		6,297,000
Research and development	44,785,000		36,830,000
Selling, general and administrative	120,787,000		98,970,000
Loss (Gain) in fair value of contingent consideration	1,512,000		(1,412,000)
Intangible asset amortization	1,572,000		1,589,000
Total operating expenses	178,445,000		142,274,000
Loss from operations	(56,982,000)		(67,275,000)
Interest expense, net	(2,431,000)	[1]	(1,082,000)
Loss before income taxes	(59,413,000)		(68,357,000)
Income tax expense	0		0
Net loss	$ (59,413,000)		$ (68,357,000)
Net loss per common share, basic	$ (1.22)		$ (1.44)
Net loss per common share, diluted	$ (1.22)		$ (1.44)
Weighted average common shares outstanding, basic	48,871,163		47,393,563
Weighted average common shares outstanding, diluted	48,871,163		47,393,563
Product Sales
Revenues [Abstract]
Revenue	$ 120,358,000		$ 74,096,000
Royalty Revenue
Revenues [Abstract]
Revenue	$ 1,105,000		$ 903,000

[1] Interest expense, net of $2,431 for the three months ended March 31, 2025 comprises (i) consolidated interest expense of $5,258 and (ii) consolidated interest income of $2,827. Interest expense, net of $1,082 for the three months ended March 31, 2024 comprises (i) consolidated interest expense of $5,406 and (ii) consolidated interest income of $4,324.